Abstract
IFN-γ is produced upon stimulation with S. aureus and may play a detrimental role during infection. However, whether hemolysins play a role in the mechanism of IFN-γ production has not been fully characterized. In this study, we demonstrated that Hlb, one of the major hemolysins of S. aureus, upregulated IFN-γ production by CD56bright NK cells from human peripheral blood mononuclear cells (PBMCs). Further investigation showed that Hlb increased calcium influx and induced phosphorylation of ERK1/2. Either blocking calcium or specifically inhibiting phosphorylation of ERK1/2 decreased the production of IFN-γ induced by Hlb. Moreover, we found that this process was dependent on the sphingomyelinase activity of Hlb. Our findings revealed a novel mechanism of IFN-γ production in NK cells induced by Hlb, which may be involved in the pathogenesis of S. aureus.
Introduction
Staphylococcus aureus (S. aureus) is an important pathogen that causes a wide range of infections, including skin infections, endocarditis or life-threatening septicemia, and pneumonia (; ). S. aureus produces four hemolysins: α-, β-, γ-, and δ-hemolysin, which are involved in the development of infectious diseases (; ). α-, γ-, and δ-hemolysin are pore-forming toxins (PFT) that can induce target cell lysis by forming pores in the cell membrane (; Wilke and Bubeck Wardenburg, 2010; ; ; ; von Hoven et al., 2019). However, β-hemolysin (Hlb) is a non-pore-forming toxin (). As a neutral sphingomyelinase (SMase), Hlb can specifically degrade sphingomyelin into ceramide and choline phosphate, which is essential for target cell membrane damage (; ). It has also been reported that Hlb forms covalent cross-links in the presence of DNA, which strongly stimulates biofilm formation in a rabbit model of infectious endocarditis (; ; ).
IFN-γ is an important cytokine produced by several cells involved in innate and adaptive immunity, including natural killer (NK) cells, natural killer T cells, cytotoxic T cells, and Th1 cells (; ). During S. aureus infection, IFN-γ is produced and cooperatively regulates host resistance with other endogenous inflammatory cytokines (; ). However, it has been observed that IFN-γ-deficient mice have higher survival rates than wild-type mice during S. aureus infection (). Neutralizing IFN-γ with anti-IFN-γ monoclonal antibodies also increased the survival rates of infected mice (). These results suggest that the production of IFN-γ induced by S. aureus is detrimental in murine models.
Yoshihara et al. reported that S. aureus stimulated the production of IFN-γ by NK cells in human PBMCs (Yoshihara et al., 1993). Moreover, the superantigen of staphylococcal enterotoxin A (SEA) expressed by S. aureus increased the expression of IFN-γ by FOXP3+ T helper cells, which was partially mediated in a monocyte-dependent manner (). In this study, we explored whether S. aureus hemolysins are involved in the production of IFN-γ. Hlb was found to induce the production of IFN-γ by human CD56bright NK cells. The increase in IFN-γ production was mediated by increased calcium and ERK1/2 phosphorylation. Furthermore, the SMase activity of Hlb was found to be essential for the production of IFN-γ.
Materials and Methods
Cells and Cell Culture
The NK-92 cell line was originally established from the PBMCs of a 50-year-old male patient with rapidly progressive non-Hodgkin’s lymphoma (). As a CD56bright NK cell line, NK-92 cells retain some crucial functional features of CD56bright NK cells, including KIRs expression (; Wu et al., 2020), granzyme K expression (), and cytokine expression (Wang et al., 2018). In this study, NK-92 cells were purchased from the China Infrastructure of Cell Line Resources. Cells were grown in α-MEM (Gibco) supplemented with 12.5% (v/v) FBS, 12.5% (v/v) horse serum, 55 mM β-mercaptoethanol, 500 U/mL IL-2, 100 U/mL penicillin, and streptomycin at 37°C in 5% CO2.
Following informed consent, PBMCs were freshly isolated from venous blood of healthy donors by density gradient centrifugation as described previously (). Fresh human whole blood was collected in tubes containing anticoagulants. Lymphocyte separation medium (TBD) was added to a fresh 15 mL conical tube, and the same volume of fresh blood was added carefully to avoid mixing the two layers. Next, the tube was centrifuged at 800 g for 30 min at room temperature. The second layer of the buffy coat was the mononuclear cell band. PBMCs were washed twice with PBS before use. Cells were grown in RPMI-1640 (Gibco) supplemented with 10% (v/v) FBS, 100 U/mL penicillin, and streptomycin at 37°C in 5% CO2.
Primary CD56bright NK cells were isolated from human PBMCs. The PBMCs were stained with antibodies: PE anti-CD56 (clone: MEM-188) and APC anti-CD3 (clone: HIT3a) (BioLegend) for 30 min at room temperature in the dark. CD56bright CD3- cells were collected using flow cytometry (BD Aria II).
Purification of Recombinant Hlb and the Site-Specific Mutants
The hlb gene (gene ID: 3238648) was amplified from the genome of S. aureus COL using the following primers:
Hlb(F): GCCATATGGCTAGCGAATCTAAGAAAGATGATAC,
Hlb(R): CACCACCCACTCGAGCTATTTACTATAGGCTTTGA,
HlbH161A(F1): GCCATATGGCTAGCGAATCTAAGAAAGATGATAC,
HlbH161A(R1): CGTTGTGGTGCTGGAGCTGATCGAAAAATTAG,
HlbH161A(F2): CTAATTTTTCGATCAGCTCCAGCACCACAACG,
HlbH161A(R2): CACCACCCACTCGAGCTATTTACTATAGGCTTTGA,
HlbH149N(F1): GCCATATGGCTAGCGAATCTAAGAAAGATGATAC,
HlbH149N(R1): CTTCAGATTGTGTATTTGTACCGATAACGTGAACG,
HlbH149N(F2): CGTTCACGTTATCGGTACAAATACACAATCTGAAG,
HlbH149N(R2): CACCACCCACTCGAGCTATTTACTATAGGCTTTGA,
HlbH288N(F): GCCATATGGCTAGCGAATCTAAGAAAGATGATAC,
HlbH288N(R):GCGCCGCTCGAGCTATTTACTATAGGCTTTGATTGGGTAATTATCTGAAAAATATT.
The underlined sequences GCTAGC and CTCGAG indicate the Nhe1 and Xho1 recognition sites, respectively. The bold letters indicate the mutation sites. The complete HlbH161A and HlbH149N genes were obtained by overlap PCR. The amplified fragments were digested with Nhe1 and Xho1 and inserted into the expression vector pET-28(a). Recombinant proteins were expressed in Escherichia coli (BL21) and purified using Ni Sepharose™ 6 Fast Flow (GE Healthcare). Purified proteins were passed through a Pierce High-Capacity Endotoxin Removal Resin (Thermo) to remove endotoxins.
Affinity Purification of Anti-Hlb Antibody
Polyclonal antibodies against Hlb were generated from New Zealand white rabbits. Rabbits were immunized with Hlb once a month, three times. The first injection was performed using 500 μL Hlb (1 mg/mL) with the same volume of Freund’s complete adjuvant (Sigma). Freund’s complete adjuvant was replaced with Freund’s incomplete adjuvant (Sigma) for the following two booster injections. After two weeks, serum was collected and rabbit antibodies against Hlb were purified using the Hlb conjugated resin as following. Recombinant Hlb was coupled with CNBr Sepharose 4B (GE Healthcare) according to the manufacturer’s instructions. The serum was then incubated with the coupling sepharose for 1 h at room temperature. Next, the coupling sepharose was washed with PBS six times. The antibody was eluted with 0.2 M Gly-HCl (pH2.4), and then neutralized with 1 M Tris-HCl (pH9.1).
All animal experimental protocols of the study are in accordance with the national guidelines for the use of animals in scientific research “Regulations for the Administration of Affairs Concerning Experimental Animals” and were approved by the Animal Care and Use Committee of Beijing Institute of Pharmacology and Toxicology.
Measurement of IFN-γ Production
For the ELISA assay, cells were incubated with a given concentration of proteins for the indicated hours at 37°C. IFN-γ in the supernatant was determined using a human IFN-γ ELISA assay kit (BioLegend) according to the manufacturer’s instructions.
For the flow cytometry assay, human PBMCs were incubated with Hlb for 12 h at 37°C. Brefeldin A (BFA) was added and the cells were continually cultured for 6 h. The treated cells were harvested and stained with antibodies: PE anti-CD56 (clone: MEM-188) and APC anti-CD3 (clone: HIT3a) (BioLegend) for 30 min at room temperature in the dark. Next, cells were washed and fixed with Fixation/Permeabilization working solution (eBioscience) for 30 min at 4°C in the dark. Cells were then washed with permeabilization buffer and stained with PerCP-Cy5.5 anti-IFN-γ antibody (clone: 4S.B3) or PerCP-Cy5.5 mouse IgG1 κ isotype control antibody (clone: MOPC-21) (BioLegend) for 30 min at room temperature in the dark. Finally, the cells were washed with permeabilization buffer and resuspended in PBS. Analysis was performed using FlowJo software (TreeStar).
For quantitative reverse transcription PCR (qRT-PCR) assays, total RNA was isolated from NK-92 cells that had already been incubated with 2 μg/mL Hlb for 12 h at 37°C using the TransZol Up Plus RNA Kit (TransGen). Next, complementary DNA was synthesized using a Revertra Ace qPCR Kit (Toyobo) and analyzed using the Bio-Rad iQ5 Real Time PCR System.
Hemolytic Activity Assays
Fresh sheep red blood cells were washed three times and diluted 50 times with PBS. Hlb was diluted to different final concentrations with 1% BSA-PBS. Then, sheep red blood cells were incubated with an equal volume of Hlb at 37°C for 1 h, followed by 4°C for 1 h. The released hemoglobin in the supernatant was collected by centrifugation and determined at 405 nm.
Western Blotting
Cells were treated in α-MEM containing 2 μg/mL Hlb for the indicated minutes. To extract total cell protein, cells were harvested after washing with cold PBS and lysed with cold RIPA lysis buffer containing protease and phosphatase inhibitors. The samples were resolved on a 12% SDS-PAGE and electroblotted onto polyvinylidene fluoride (PVDF) membranes. Anti-STAT5A Ab, phospho-STAT5A Ab (BBI Life Sciences), phospho-STAT4 Ab, STAT4 rabbit mAb, NF-κB p65 rabbit mAb, phospho-NF-κB p65 rabbit mAb, p44/42 MAPK rabbit mAb, phospho-p44/42 MAPK rabbit mAb (Cell Signaling Technology), anti-GAPDH, and horseradish peroxidase-conjugated goat antibodies against rabbit IgG and mouse IgG (Jackson ImmunoResearch Laboratories) were used. Finally, the blots were detected using Pierce™ ECL Western Blotting Substrate (Thermo).
Measurement of Intracellular Calcium
NK-92 cells were washed three times with HBSS (Beyotime) and incubated with 5 μM Fluo-3-AM (Beyotime) at 37°C for 45 min. Next, the cells were washed with HBSS three times and resuspended in 500 μL HBSS (containing Ca2+, Mg2+) supplemented with 10 mM HEPES (pH 7.5) and 1 mg/mL BSA. Finally, cells were analyzed using flow cytometry (BD Aria II) for 5 min.
Detection of NK-92 Cell Binding With Hlb
NK-92 cells were incubated with 10 μg/mL Hlb in α-MEM (Gibco) for 1 h at 37°C. The cells were then collected and washed with 1% BSA-PBS by centrifugation. Next, the cells were incubated with an anti-6xHis tag antibody (FITC) in 1% BSA-PBS for 30 min at room temperature. Finally, the cells were washed with PBS and analyzed using flow cytometry (BD Aria II).
Measurement of Lymphocyte Death
Human PBMCs were incubated with Hlb, HlgA/B, or Hla at 37°C for 12 h. The cells were then collected and stained with 7-AAD (BioLegend) according to the manufacturer’s instructions. The treated cells were analyzed using flow cytometry (BD Aria II) within 30 min.
Construction of hlb-Deletion Mutant (COLΔhlb) From the S. aureus COL
The mutant was constructed based on homologous recombination (). The gene fragments upstream and downstream of the hlb gene from S. aureus COL genomic DNA were amplified using PCR. The kanamycin resistance gene from S. aureus 8325-4ΔVrax was also amplified using PCR. The pBT2 plasmid containing a homologous recombination fragment (upstream gene—kanamycin resistance gene—downstream gene) was constructed using enzyme digestion and ligation. Next, the plasmid was electroporated into COL. Homologous recombination between the bacterial genome and plasmid was induced by changing the temperature and kanamycin concentration. The mutant strains were screened by growing on plates containing kanamycin and chloramphenicol. Strains that grew on the kanamycin plate but not on the kanamycin and chloramphenicol plates were verified using PCR.
S. aureus COL and COLΔhlb were individually cultured in BHI medium (BD) at 37°C for 12 h. The supernatant was collected and dialyzed in distilled water. It was then lyophilized and re-dissolved with 1/10 volume of PBS and concentrated 10 times.
Statistical Analysis
GraphPad Prism software was used for data presentation and statistical analyses. Statistical analyses were performed using one-way analysis of variance (ANOVA). All experiments were repeated at least three times independently, and the data are expressed as the mean ± standard deviation (s.d). Statistical significance was set at P < 0.05.
Results
Hlb Enhanced the Production of IFN-γ in CD56bright NK Cells in Human Peripheral Blood Mononuclear Cells
As S. aureus stimulated the production of IFN-γ in human PBMCs (Yoshihara et al., 1993; ) and hemolysins-assisted immune escape during the pathogenesis of S. aureus (; Wilke and Bubeck Wardenburg, 2010; von Hoven et al., 2019), we determined that S. aureus hemolysins are involved in IFN-γ production. We expressed and purified three kinds of hemolysins, Hla, Hlb, and HlgA/HlgB (Supplementary Material S1). The purified toxins were then incubated with human PBMCs. The results of flow cytometry indicated that these hemolysins at the given certain concentration (4 μg/mL Hlb, 4 μg/mL HlgA/B, or 0.25 μg/mL Hla) did not induce lymphocyte death (Supplementary Material S2). The production of IFN-γ by PBMCs after incubation with different toxins was determined using ELISA. Hlb stimulated the production of IFN-γ, while the other two hemolysins had no effect (Figure 1A). Moreover, the production of IFN-γ stimulated by Hlb was concentration-dependent (Figure 1B). IFN-γ production in the different cell subsets of PBMCs was further detected by staining for CD56 and CD3 with specific antibodies. It was shown that the upregulated IFN-γ expression was observed in CD56bright NK cells [CD56bright CD3-] after human PBMCs were incubated with Hlb (Figure 1C), and Hlb was found to increase the percentage of IFN-γ-producing cells in CD56bright NK cells in a concentration-dependent manner (Figure 1D). Human NK cells can be subdivided into two subsets (CD56bright and CD56dim NK cells) based on the relative expression of CD56. CD56bright NK cells are considered efficient cytokine producers endowed with immunoregulatory properties, but they can also become cytotoxic upon appropriate activation (; ; Wagner et al., 2017).
Figure 1
NK-92 is a CD56bright NK cell line that retains some crucial functional features of CD56bright NK cells, including cytokine expression (; Wang et al., 2018). Therefore, we used NK-92 cells for further mechanistic investigations. As expected, Hlb induced a marked increase in IFN-γ production by NK-92 cells in a concentration-and time-dependent manner (Figures 1E, F). Moreover, we found that the level of IFN-γ mRNA in NK-92 cells increased after incubation with Hlb (Supplementary Material S3). Rabbit polyclonal antibodies against Hlb (anti-Hlb) were prepared (Supplementary Material S4). Further investigation demonstrated that anti-Hlb blocked IFN-γ production induced by Hlb (Figure 1G).
S. aureus COL is a methicillin-resistant Staphylococcus aureus (MRSA) strain with a known complete genome. It was reportedly isolated in the early 1960s from the operating theater in a hospital in Colindale, England (). To further confirm whether Hlb induced the production of IFN-γ in NK-92 cells, an hlb-deletion mutant (COLΔhlb) from S. aureus COL was generated. The supernatant collected from COL or COLΔhlb was incubated with NK-92 cells. The level of IFN-γ stimulated by COL supernatant was significantly higher than that stimulated by COLΔhlb supernatant (Figure 1H).
Phosphorylation of ERK1/2 Modulated IFN-γ Production Induced by Hlb
It has been reported that the activation of several intracellular molecules, including STAT4 (; ), STAT5 (), NF-κB (Vulpis et al., 2017), and ERK1/2 (Yu et al., 2000) regulate the transcription of IFN-γ in NK cells. Therefore, the phosphorylation of these molecules was measured in NK-92 cells. It was found that phosphorylation of ERK1/2 but not STAT4, STAT5, or NF-κB (p65) was increased (Figure 2A), and the phosphorylation of ERK1/2 stimulated by Hlb was blocked by the MEK1/2 inhibitor U0126 (Figure 2B). In line with our expectations, the increased level of IFN-γ mRNA and the elevated IFN-γ production in NK-92 cells induced by Hlb was blocked by U0126 (Figures 2C, D).
Figure 2
Intracellular Calcium Was Increased by Hlb
As α-hemolysin and γ-hemolysin are reported to bind specific receptors on cell membranes (Wilke and Bubeck Wardenburg, 2010; ), we wondered whether Hlb also directly bond to CD56bright NK cells. The results of flow cytometry showed that Hlb did not bind to NK-92 cells (Supplementary Material S5). Given that intracellular calcium induces the activation of ERK1/2 (; ), we explored whether Hlb increased intracellular calcium in NK-92 cells. It was found that the level of intracellular calcium immediately increased with the addition of Hlb (Figure 3A). However, the intracellular calcium concentration was not elevated when Hlb was pre-incubated with anti-Hlb (Figure 3A). Ethylene glycol-bis(2-aminoethylether)-N,N’,N’,N’-tetraacetic acid (EGTA) is a specific chelator of Ca2+. The intracellular calcium stimulated by Hlb was partially blocked when EGTA was added (Figure 3B). In addition, ERK1/2 phosphorylation and IFN-γ production induced by Hlb were blocked by EGTA addition (Figures 3C, 3D).
Figure 3
IFN-γ Expression Induced by Hlb Is Dependent on Its SMase Activity
Hlb is a neutral SMase and a DNA biofilm ligase. To further explore the mechanisms of action that contributed to the increased production of IFN-γ induced by Hlb, we constructed and purified recombinant SMase-deficient Hlb mutants (HlbH288N, HlbH149N) and biofilm ligase-deficient Hlb mutants (HlbH161A) (; ; ) (Supplementary Material S6). As a neutral SMase, Hlb cleaves sphingomyelin and induces lysis of sheep red blood cells (RBCs) (; ). We analyzed the released hemoglobin in the supernatant of sheep RBCs after incubation with these mutants. Hlb and HlbH161A were found to lyse sheep RBCs at a low concentration (8 ng/mL). However, sheep RBCs were resistant to lysis mediated by either HlbH288N or HlbH149N (Supplementary Material S7). IFN-γ production was analyzed in NK-92 cells after incubation with these mutants. The results showed that HlbH288N and HlbH149N failed to induce IFN-γ production in NK-92 cells, while HlbH161A had an effect similar to that of Hlb (Figure 4A).
Figure 4
U0126 and EGTA may directly inhibit the SMase activity of Hlb, thereby blocking the production of IFN-γ induced by Hlb. Therefore, we investigated whether U0126 and EGTA inhibited the SMase activity of Hlb. Sheep RBCs were incubated with Hlb in the presence of U0126 or EGTA, and the released hemoglobin in the supernatant was measured. The results showed that the lysis of sheep RBCs mediated by Hlb was not altered by the addition of U0126 or EGTA (Supplementary Material S8a, S8b).
For further investigation, the primary CD56bright NK cells in human PBMCs from healthy donors were isolated and incubated with Hlb or HlbH288N. Consistent with the observation in NK-92 cells, the production of IFN-γ by primary CD56bright NK cells was enhanced by incubation with Hlb but not HlbH288N (Figure 4B). Meanwhile, it was observed that the phosphorylation of ERK in CD56bright NK cells was induced by Hlb (Figure 4C).
Discussion
As a hemolysin expressed by S. aureus, Hlb, a non-PFT hemolysin, is a neutral SMase. Here, we found that Hlb induced the production of IFN-γ in human CD56bright NK cells. Previous studies have shown that the combination of IL-12 and IL-18 is usually used to induce the production of IFN-γ in CD56bright NK cells, which is mediated by the activation of STAT4 (; ; ; ). However, we found that phosphorylation of ERK1/2, but not STAT4, was stimulated by Hlb, suggesting that the mechanism of IFN-γ production triggered by Hlb was different from that of other triggering factors.
IFN-γ is an important cytokine produced by several cells involved in innate and adaptive immunity, including natural killer (NK) cells, natural killer T cells, cytotoxic T cells, and Th1 cells. However, the production of IFN-γ in these cells is regulated by different mechanisms. In our study, we observed that the production of IFN-γ induced by Hlb was only in CD56bright NK cells. We speculated that the production of IFN-γ in CD56bright NK cells was more susceptible to the degradation of sphingomyelin induced by Hlb compared with other IFN-γ producing cells, which needs to be investigated in the future.
The sequenced genome revealed that S.aureus COL express enterotoxins (SEA, SEB, SEl-K and SEl-I), but did not express toxic shock syndrome toxin (). It has been reported that enterotoxins characterized as the superantigens bind MHC-II molecules and coordinate to T cell receptors. S.aureus enterotoxins induce massive nonspecific proliferation of T cells, which leads to release of IFN-γ (). The direct effect of enterotoxins on NK cells has not been reported.
We performed flow cytometry to detect whether Hlb directly bond to NK-92 cells. It was found that Hlb did not directly bind to NK-92 cells, suggesting that there was no specific receptor for Hlb on the cell membrane. However, both HlbH288N and HlbH149N failed to stimulate the production of IFN-γ, which indicated that the SMase activity of Hlb played a crucial role in this process. We speculated that there might be two mechanisms for Hlb to stimulate calcium influx and upregulate the expression of IFN-γ through its sphingomyelinase activity. On one hand, ceramide might trigger intracellular signaling pathways leading to calcium influx. Sphingomyelin is one of the major components of mammalian cell membranes. In the presence of Mg2+, Hlb cleaves sphingomyelin into ceramide and phosphorylcholine. Ceramide is an intracellular signaling molecule that shows activity in many biological processes (). Studies have shown that bacterial SMase can activate the sphingomyelin pathway directly (). Bacterial SMase increases intracellular Ca2+ concentration in primary cultured cerebral vascular smooth muscle cells (Zheng et al., 2000). On the other hand, Ca2+ influx is regulated by ion channels located on the cell membrane (). It has been reported that the degradation of sphingomyelin mediated by SMase induces the formation of ceramide-enriched domains in cell membrane (). Meanwhile, Hlb has been identified to induce the shedding of cell membrane proteins (). We assumed that the altered cell membrane and the shedding of cell membrane proteins mediated by Hlb might trigger Ca2+ influx. The mechanism in detail will be investigated in the future. In addition, neutral SMase is reported to be expressed in several bacteria, such as Bacillus cereus, Listeria ivanovii (; ). All of these SMases hydrolyze sphingomyelin into ceramide and phosphocholine, so they may also induce the response of NK cells and upregulate the expression of IFN-γ.
It is well known that most of human S. aureus isolates do not express functional Hlb, which is due to the integration of bacteriophages into the structural gene hlb (; ). Therefore, it has been assumed that Hlb does not significantly contribute to pathogenesis during S. aureus infection. However, evidences demonstrate that in some conditions, precise excision of the bacteriophage occurs, leading to the re-production of Hlb. Phage excision with Hlb expression has been reported in S. aureus isolates from patients with cystic fibrosis (CF) (). Strain 8325-4φ13 and S. aureus isolated from CF patients harboring φ13-like phages could be detected as Hlb-positive after treatment with either ciprofloxacin or trimethoprim (). In the mouse ear skin colonization model, the spontaneous precise excision of the bacteriophage significantly improved the colonization ability of the MW2 strain (). Moreover, it has been identified that strains carrying phage φSa3 exist as heterogeneous populations containing a subset producing Hlb. The frequency of colonies producing Hlb in stains carrying phage φSa3 is dependent on the growth condition in vitro and in vivo. Re-producing of Hlb aggravates pneumonia and infective endocarditis in rabbit models, which suggests that Hlb contributes significantly to tissue disease progression (). These studies suggest that during chronic infections, Hlb production may be beneficial for S. aureus to resist antibiotics and the host immune system, thus further promoting disease progression. We found that Hlb induced the production of IFN-γ in human CD56bright NK cells. Previous studies have shown that the production of endogenous IFN-γ aggravates S. aureus infection in vivo (; ; ; ). Therefore, the production of IFN-γ in NK cells induced by Hlb may be a new mechanism that aggravates S. aureus infection. As there is no cell subpopulation in mice corresponding to human CD56bright NK cells, we did not investigate the effect of IFN-γ production induced by Hlb on S. aureus pathogenesis in a murine model.
In addition, S. aureus is widely colonized in the human body that is correlated with the development of many persistent severe inflammatory diseases, such as atopic dermatitis (Weidinger et al., 2018; ), systemic lupus erythematosus (), diabetes (), and insulin resistance (). IFN-γ is reported to be involved in the development of these diseases (; ; ). Therefore, we speculate that the expression of Hlb during S. aureus colonization may contribute to chronic inflammatory diseases. In summary, we have identified that β-hemolysin directly upregulates the expression of IFN-γ in human CD56bright NK cells, which is dependent on its SMase activity. Our findings present an additional novel mechanism of IFN-γ production induced by S. aureus, which may be involved in its pathogenesis.
Funding
This work was supported by grants from National Natural Science Foundation of China (http://www.nsfc.gov.cn) [81871618] and Shandong Provincial Major Scientific and Technological Innovation Project (MSTIP) [2019JZZY011012]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Author contributions
ZG prepared Figures 1–4 and wrote the manuscript text. YL and CL prepared Figures 2, 3. HW prepared Figure 1. JF supervised the study and drafted the manuscript. GY conceived and designed the study, obtained funding and drafted the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2021.658141/full#supplementary-material
References
1
AgellN.BachsO.RocamoraN.VillalongaP. (2002). Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and Calmodulin. Cell Signal.14, 649–654. doi: 10.1016/s0898-6568(02)00007-4
2
AntonelliA.FerrariS. M.GiuggioliD.FerranniniE.FerriC.FallahiP. (2014). Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev.13, 272–280. doi: 10.1016/j.autrev.2013.10.010
3
BjörkanderS.HellL.JohanssonM. A.ForsbergM. M.LasaviciuteG.RoosS.et al. (2016). Staphylococcus aureus-derived factors induce IL-10, IFN-γ and IL-17A-expressing FOXP3+CD161+ T-helper cells in a partly monocyte-dependent manner. Sci. Rep.6, 22083. doi: 10.1038/srep22083
4
BownikA.SiwickiA. K. (2008). Effects of staphylococcal hemolysins on the immune system of vertebrates. Centr Eur. J. Immunol.33, 87–90.
5
BrücknerR. (1997). Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol. Lett.151, 1–8. doi: 10.1111/j.1574-6968.1997.tb10387.x
6
BurkeJ. D.YoungH. A. (2019). IFN-γ: A cytokine at the right time, is in the right place. Semin. Immunol.43, 101280. doi: 10.1016/j.smim.2019.05.002
7
CameronS. B.NawijnM. C.KumW. W.SavelkoulH. F.ChowA. W. (2001). Regulation of helper T cell responses to staphylococcal superantigens. Eur. Cytokine Netw.12, 210–222.
8
CastroB. M.PrietoM.SilvaL. C. (2014). Ceramide: a simple sphingolipid with unique biophysical properties. Prog. Lipid Res.54, 53–67. doi: 10.1016/j.plipres.2014.01.004
9
ClarkeC. J.SnookC. F.TaniM.MatmatiN.MarchesiniN.HannunY. A. (2006). The extended family of neutral sphingomyelinases. Biochemistry45, 11247–11256. doi: 10.1021/bi061307z
10
ContiF.CeccarelliF.IaianiG.PerriconeC.GiordanoA.AmoriL.et al. (2016). Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus. Arthritis Res. Ther.18, 177. doi: 10.1186/s13075-016-1079-x
11
CulshawS.LeungB. P.GracieJ. A.CampbellC. C.ThomsonD.GemmellC. (2005). Prior elevation of IL-18 promotes rapid early IFN-gamma production during staphylococcal infection. Eur. J. Immunol.35, 1438–1444. doi: 10.1002/eji.200425661
12
Di BariF. (2015). Atopic dermatitis and alpha-chemokines. Clin. Ter166, e182–e187. doi: 10.7417/CT.2015.1852
13
DingesM. M.OrwinP. M.SchlievertP. M. (2000). Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev.13, 16–34. doi: 10.1128/cmr.13.1.16-34.2000
14
DoeryH. M.MagnussonB. J.GulasekharamJ.PearsonJ. E. (1965). The properties of phospholipase enzymes in staphylococcal toxins. J. Gen. Microbiol.40, 283–296. doi: 10.1099/00221287-40-2-283
15
DrydenM.BaguneidM.EckmannC.CormanS.StephensJ.SolemC.et al. (2015). Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clin. Microbiol. Infect.Suppl 2, S27–S32. doi: 10.1016/j.cmi.2015.03.024
16
FehnigerT. A.ShahM. H.TurnerM. J.VanDeusenJ. B.WhitmanS. P.CooperM. A.et al. (1999). Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol.162, 4511–4520.
17
GillS. R.FoutsD. E.ArcherG. L.MongodinE. F.DeboyR. T.RavelJ.et al. (2005). Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol.187, 2426–2438. doi: 10.1128/JB.187.7.2426-2438.2005
18
GoerkeC.Matias y PapenbergS.DasbachS.DietzK.ZiebachR.KahlB. C.et al. (2004). Increased frequency of genomic alterations in Staphylococcus aureus during chronic infection is in part due to phage mobilization. J. Infect. Dis.189, 724–734. doi: 10.1086/381502
19
GoerkeC.WirtzC.FlückigerU.WolzC. (2006). Extensive phage dynamics in Staphylococcus aureus contributes to adaptation to the human host during infection. Mol. Microbiol.61, 1673–1685. doi: 10.1111/j.1365-2958.2006.05354.x
20
GongJ. H.MakiG.KlingemannH. G. (1994). Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia8, 652–658.
21
GongD.ZhangJ.ChenY.XuY.MaJ.HuG.et al. (2019). The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway. J. Exp. Clin. Cancer Res.38, 233. doi: 10.1186/s13046-019-1223-y
22
GotthardtD.PutzE. M.GrundschoberE.Prchal-MurphyM.StrakaE.KudweisP.et al. (2016). STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion. Cancer Discov.6, 414–429. doi: 10.1158/2159-8290.CD-15-0732
23
HagbergN.JoelssonM.LeonardD.ReidS.ElorantaM. L.MoJ.et al. (2018). The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE. Ann. Rheum Dis.77, 1070–1077. doi: 10.1136/annrheumdis-2017-212794
24
HerreraA.VuB. G.StachC. S.MerrimanJ. A.HorswillA. R.Salgado-PabónW.et al. (2016). Staphylococcus aureus β-Toxin Mutants Are Defective in Biofilm Ligase and Sphingomyelinase Activity, and Causation of Infective Endocarditis/Sepsis. Biochemistry55, 2510–2517. doi: 10.1021/acs.biochem.6b00083
25
HerreraA.KulhankovaK.SonkarV. K.DayalS.KlingelhutzA. J.Salgado-PabónW.et al. (2017). Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities. MBio8, e00273–e00217. doi: 10.1128/mBio.00273-17
26
HigdonL. E.LeeK.TangQ.MaltzmanJ. S. (2016). Virtual Global Transplant Laboratory Standard Operating Procedures for Blood Collection, PBMC Isolation, and Storage. Transplant. Direct2, e101. doi: 10.1097/TXD.0000000000000613
27
HusebyM.ShiK.BrownC. K.DigreJ.MengistuF.SeoK. S.et al. (2007). Structure and biological activities of beta toxin from Staphylococcus aureus. J. Bacteriol.189, 8719–8726. doi: 10.1128/JB.00741-07
28
HusebyM. J.KruseA. C.DigreJ.KohlerP. L.VockeJ. A.MannE. E.et al. (2010). Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc. Natl. Acad. Sci. U. S. A.107, 14407–14412. doi: 10.1073/pnas.0911032107
29
JiangW.ChaiN. R.MaricD.BielekovaB. (2011). Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis. J. Immunol.187, 781–790. doi: 10.4049/jimmunol.1100789
30
KatayamaY.BabaT.SekineM.FukudaM.HiramatsuK. (2013). Beta-hemolysin promotes skin colonization by Staphylococcus aureus. J. Bacteriol.195, 1194–1203. doi: 10.1128/JB.01786-12
31
KimM. Y.LinardicC.ObeidL.HannunY. (1991). Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J. Biol. Chem.266, 484–489. doi: 10.1016/S0021-9258(18)52461-3
32
KlunkerS.TrautmannA.AkdisM.VerhagenJ.Schmid-GrendelmeierP.BlaserK.et al. (2003). A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J. Immunol.171, 1078–1084. doi: 10.4049/jimmunol.171.2.1078
33
LiuY.LiuF. J.GuanZ. C.DongF. T.ChengJ. H.GaoY. P.et al. (2018). The extracellular domain of Staphylococcus aureus LtaS binds insulin and induces insulin resistance during infection. Nat. Microbiol.3, 622–631. doi: 10.1038/s41564-018-0146-2
34
MatikainenS.PaananenA.MiettinenM.KurimotoM.TimonenT.JulkunenI.et al. (2001). IFN-α and IL-18 synergistically enhance IFN-γ production in human NK cells: differential regulation of Stat4 activation and IFN-γ gene expression by IFN-α and IL-12. Eur. J. Immunol.31, 2236–2245. doi: 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G
35
MichelT.PoliA.CuapioA.BriquemontB.IserentantG.OllertM.et al. (2016). Human CD56bright NK Cells: An Update. J. Immunol.196, 2923–2931. doi: 10.4049/jimmunol.1502570
36
MojicM.TakedaK.HayakawaY. (2017). The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion. Int. J. Mol. Sci.19:89. doi: 10.3390/ijms19010089
37
MontesL. R.LópezD. J.SotJ.BagatolliL. A.StonehouseM. J.VasilM. L.et al. (2008). Ceramide-enriched membrane domains in red blood cells and the mechanism of sphingomyelinase-induced hot-cold hemolysis. Biochemistry47, 11222–11230. doi: 10.1021/bi801139z
38
NakaneA.OkamotoM.AsanoM.KohanawaM.MinagawaT. (1995). Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun.63, 1165–1172. doi: 10.1128/IAI.63.4.1165-1172.1995
39
NguyenK. B.WatfordW. T.SalomonR.HofmannS. R.PienG. C.MorinobuA.et al. (2002). Critical role for STAT4 activation by type 1 interferons in the interferon- response to viral infection. Science297, 2063–2066. doi: 10.1126/science.1074900
40
OliveiraD.BorgesA.SimõesM. (2018). Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases. Toxins (Basel)10:252. doi: 10.3390/toxins10060252
41
PantucekR.DoskarJ.RuzickovaV.KasparekP.OracovaE.KvardovaV.et al. (2004). Identification of bacteriophage types and their carriage in Staphylococcus aureus. Arch. Virol.149, 1689–1703. doi: 10.1007/s00705-004-0335-6
42
ParkP. W.FosterT. J.NishiE.DuncanS. J.KlagsbrunM.ChenY. (2004). Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin. J. Biol. Chem.279, 251–258. doi: 10.1074/jbc.M308537200
43
PoliA.MichelT.ThérésineM.AndrèsE.HentgesF.ZimmerJ. (2009). CD56bright natural killer (NK) cells: an important NK cell subset. Immunology126, 458–465. doi: 10.1111/j.1365-2567.2008.03027.x
44
PowersM. E.KimH. K.WangY.Bubeck WardenburgJ. (2012). ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J. Infect. Dis.206, 352–356. doi: 10.1093/infdis/jis192
45
RedmondJ.O’RilleyD.BuchananP. (2017). Role of ion channels in natural killer cell function towards cancer. Discov. Med.23, 353–360.
46
Salgado-PabónW.HerreraA.VuB. G.StachC. S.MerrimanJ. A.SpauldingA. R.et al. (2014). Staphylococcus aureus β-toxin production is common in strains with the β-toxin gene inactivated by bacteriophage. J. Infect. Dis.210, 784–792. doi: 10.1093/infdis/jiu146
47
SasakiS.NishikawaS.MiuraT.MizukiM.YamadaK.MadarameH.et al. (2000). Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect. Immun.68, 2424–2430. doi: 10.1128/iai.68.5.2424-2430.2000
48
SatorresS. E.AlcarázL. E.CargneluttiE.Di GenaroM. S. (2009). IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus. Immunol. Lett123, 185–188. doi: 10.1016/j.imlet.2009.03.003
49
SpaanA. N.VrielingM.WalletP.BadiouC.Reyes-RoblesT.OhneckE. A.et al. (2014). The staphylococcal toxins γ-hemelysin AB and CBdifferentially target phagocytes by employing specific chemokine receptors. Nat. Commun.5, 5438. doi: 10.1038/ncomms6438
50
SpaanA. N.Reyes-RoblesT.BadiouC.CochetS.BoguslawskiK. M.YoongP.et al. (2015). Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes. Cell Host Microbe18, 363–370. doi: 10.1016/j.chom.2015.08.001
51
TalbotJ. C.ThiaudièreE.VincentM.GallayJ.SiffertO.DufourcqJ. (2001). Dynamics and orientation of amphipathic peptides in solution and bound to membranes: a steady-state and time-resolved fluorescence study of staphylococcal delta-toxin and its synthetic analogues. Eur. Biophys. J.30, 147–161. doi: 10.1007/s002490000118
52
ThierfelderW. E.van DeursenJ. M.YamamotoK.TrippR. A.SarawarS. R.CarsonR. T.et al. (1996). Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature382, 171–174. doi: 10.1038/382171a0
53
TongS. Y.DavisJ. S.EichenbergerE.HollandT. L.FowlerV.G.Jr. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev.28, 603–661. doi: 10.1128/CMR.00134-14
54
TrundleyA. E.HibyS. E.ChangC.SharkeyA. M.SantourlidisS.UhrbergM.et al. (2006). Molecular characterization of KIR3DL3. Immunogenetics57, 904–916. doi: 10.1007/s00251-005-0060-7
55
van WamelW. J.RooijakkersS. H.RuykenM.van KesselK. P.van StrijpJ. A. (2006). The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J. Bacteriol.188, 1310–1315. doi: 10.1128/JB.188.4.1310-1315.2006
56
VandeneschF.LinaG.HenryT. (2012). Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front. Cell Infect. Microbiol.2:12. doi: 10.3389/fcimb.2012.00012
57
VickeryT. W.RamakrishnanV. R.SuhJ. D. (2019). The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis. Curr. Allergy Asthma Rep.19, 21. doi: 10.1007/s11882-019-0853-7
58
von HovenG.QinQ.NeukirchC.HusmannM.HellmannN. (2019). Staphylococcus aureus α-toxin: small pore, large consequences. Biol. Chem.400, 1261–1276. doi: 10.1515/hsz-2018-0472
59
VulpisE.CecereF.MolfettaR.SorianiA.FiondaC.PeruzziG.et al. (2017). Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-κB axis. Oncoimmunology6, e1279372. doi: 10.1080/2162402X.2017.1279372
60
WagnerJ. A.RosarioM.RomeeR.Berrien-ElliottM. M.SchneiderS. E.LeongJ. W.et al. (2017). CD56bright NK cells exhibit potent antitumor responses following IL-15 priming. J. Clin. Invest127, 4042–4058. doi: 10.1172/JCI90387
61
WangH.ZhangY.WuX.WangY.CuiH.LiX.et al. (2018). Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway. Front. Immunol.9:293. doi: 10.3389/fimmu.2018.00293
62
WeidingerS.BeckL. A.BieberT.KabashimaK.IrvineA. D. (2018). Atopic dermatitis. Nat. Rev. Dis. Primers4:1. doi: 10.1038/s41572-018-0001-z
63
WilkeG. A.Bubeck WardenburgJ. (2010). Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin mediated cellular injury. Proc. Natl. Acad. Sci. U. S. A.107, 13473–13478. doi: 10.1073/pnas.1001815107
64
WuC. Y.ZhangB.KimH.AndersonS. K.MillerJ. S.CichockiF. (2020). Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation. J. Immunol.205, 1513–1523. doi: 10.4049/jimmunol.2000212
65
YoshiharaR.ShiozawaS.FujitaT.ChiharaK. (1993). Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation. Infect. Immun.61, 3117–3122. doi: 10.1128/IAI.61.8.3117-3122.1993
66
YuT. K.CaudellE. G.SmidC.GrimmE. A. (2000). IL-2 Activation of NK Cells: Involvement of MKK1/2/ERK But Not p38 Kinase Pathway. J. Immunol.164, 6244–6251. doi: 10.4049/jimmunol.164.12.6244
67
ZhengT.LiW.WangJ.AlturaB. T.AlturaB. M. (2000). Sphingomyelinase and ceramide analogs induce contraction and rises in [Ca(2+)](i) in canine cerebral vascular muscle. Am. J. Physiol. Heart Circ. Physiol.278, 1421–1428. doi: 10.1152/ajpheart.2000.278.5.H1421
Summary
Keywords
S. aureus, β-hemolysin, IFN-γ, CD56bright NK cells, ERK, calcium
Citation
Guan Z, Liu Y, Liu C, Wang H, Feng J and Yang G (2021) Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56bright NK Cells. Front. Cell. Infect. Microbiol. 11:658141. doi: 10.3389/fcimb.2021.658141
Received
25 January 2021
Accepted
11 March 2021
Published
29 March 2021
Volume
11 - 2021
Edited by
Vera Kozjak-Pavlovic, Julius Maximilian University of Würzburg, Germany
Reviewed by
Jere W. McBride, University of Texas Medical Branch at Galveston, United States; Barbara C. Kahl, University of Münster, Germany; Christiane Wolz, University of Tübingen, Germany
Updates
Copyright
© 2021 Guan, Liu, Liu, Wang, Feng and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guang Yang, yangg62033@outlook.com
This article was submitted to Bacteria and Host, a section of the journal Frontiers in Cellular and Infection Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.